Marketing authorized for endoscopic sleeve gastroplasty systems
The systems are the first to be authorized by the FDA for the minimally invasive weight-loss procedure, which is intended for adults with obesity who have not been able to lose weight or maintain weight loss through measures such as diet and exercise.
On July 12, the FDA authorized marketing of the Apollo Endoscopic Sleeve Gastroplasty and Revise systems for endoscopic sleeve gastroplasty, the agency said in a news release.
The systems are the first to be authorized by the FDA for the minimally invasive weight-loss procedure. The procedure is intended for adults with obesity who have not been able to lose weight or maintain weight loss through more conservative measures such as diet and exercise. In the procedure, a suturing device and camera are passed down the esophagus to the stomach and used to place sutures inside the stomach to reduce the stomach's volume.